NL-OMON26839尚未招募不适用
Immunological response after early extra and regular MMR immunization; 6 years follow-up
RIVM0 个研究点目标入组 105 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 105
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- •Participation in the study on the immunological effects of early measles vaccination, as described in a separate study protocol (NL45616.094.13/IIV-273)
- •The parents/legally representatives accept participation in the trial according to the described procedures
- •Presence of a signed informed consent
- •Children must have received their NIP vaccinations according to schedule.
排除标准
- •A potential subject who meets any of the following criteria will be excluded from participation in this study:
- •Receiving immunosuppressive medication
- •Presence of a serious disease that requires medical care that can interfere with the results of the study
- •Known or suspected immunological disorder
- •Bleeding disorders
研究者
相似试验
招募中
不适用
Immunological response after early extra and regular MMR immunization; 10 years follow-upNL-OMON56402RIVM80
已完成
不适用
Immunological response after early extra and regular MMR immunization; 6 years follow-upNL-OMON48447RIVM90
进行中（未招募）
1 期
Evaluation of immunological response following a revaccination with a non-conjugated pneumococcal vaccine boosted or not by a conjugated pneumococcal vaccine in splenectomised patients (SPLENEVAC-2)Asplenic patients at risk for invasive pneumococcal diseasesMedDRA version: 20.0Level: PTClassification code 10041642Term: SplenectomySystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2018-003068-29-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)56
尚未招募
Unknown
Association of immunological response with the presence or absence of oral mood stabilizers in schizophrenia patients infected with COVID-19Patients with schizophreniaJPRN-UMIN000050395Kurita hospital50
已完成
不适用
Prospective study on early immune response to factor VIII exposure in previously untreated patients with severe hemophilia ABleeding disorderHaemophilia A10064477NL-OMON33198Academisch Medisch Centrum20